Terms: = Prostate cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
40 results:
1. Apoptotic Potential of Glucomoringin Isothiocyanate (GMG-ITC) Isolated from
Abd Karim NA; Adam AHB; Jaafaru MS; Rukayadi Y; Abdull Razis AF
Molecules; 2023 Apr; 28(7):. PubMed ID: 37049977
[TBL] [Abstract] [Full Text] [Related]
2. Ugi Cascade Sequence for the Construction of 3-Pyrrolin-2-one Scaffolds: Anti-proliferation in prostate cancer Cells.
Lei J; Yang DL; Xu J; Li J; Zhang GY; Xiong X; Zhou CH; Xu ZG; Chen ZZ
Chem Asian J; 2022 Dec; 17(24):e202200977. PubMed ID: 36322683
[TBL] [Abstract] [Full Text] [Related]
3. Differential impact of PI3K/AKT/mTOR signaling on tumor initiation and progression in animal models of prostate cancer.
Wang S; Zhang C; Xu Z; Chen MH; Yu H; Wang L; Liu R
Prostate; 2023 Jan; 83(1):97-108. PubMed ID: 36164668
[TBL] [Abstract] [Full Text] [Related]
4. Antiproliferative and Oxidative Damage Protection Activities of Endophytic Fungi Aspergillus fumigatus and Chaetomium globosum from Moringa oleifera lam.
Kaur N; Arora DS; Kaur S; Kumar A; Kaur S
Appl Biochem Biotechnol; 2021 Nov; 193(11):3570-3585. PubMed ID: 34313919
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.
Signore M; Alfonsi R; Federici G; Nanni S; Addario A; Bertuccini L; Aiello A; Di Pace AL; Sperduti I; Muto G; Giacobbe A; Collura D; Brunetto L; Simone G; Costantini M; Crinò L; Rossi S; Tabolacci C; Diociaiuti M; Merlino T; Gallucci M; Sentinelli S; Papalia R; De Maria R; Bonci D
Cell Death Dis; 2021 Jun; 12(7):636. PubMed ID: 34155195
[TBL] [Abstract] [Full Text] [Related]
6. Alternative splicing regulation by the androgen receptor in prostate cancer cells.
Germain L; Lafront C; Beaudette J; Karthik Poluri RT; Weidmann C; Audet-Walsh É
J Steroid Biochem Mol Biol; 2020 Sep; 202():105710. PubMed ID: 32534106
[TBL] [Abstract] [Full Text] [Related]
7. Isolation and characterization of flavonoid derivatives with anti-prostate cancer and hepatoprotective activities from the flowers of Hosta plantaginea (lam.) Aschers.
Wei R; Ma Q; Zhong G; He J; Sang Z
J Ethnopharmacol; 2020 May; 253():112685. PubMed ID: 32101774
[TBL] [Abstract] [Full Text] [Related]
8. Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells.
Fatma Karaman E; Caglayan M; Sancar-Bas S; Ozal-Coskun C; Arda-Pirincci P; Ozden S
Environ Pollut; 2019 Dec; 255(Pt 2):113318. PubMed ID: 31610501
[TBL] [Abstract] [Full Text] [Related]
9.
Kim SH; Park WS; Chung J
Investig Clin Urol; 2019 May; 60(3):148-155. PubMed ID: 31098421
[TBL] [Abstract] [Full Text] [Related]
10. Pelvic magnetic resonance imaging parameters predict urinary incontinence after robot-assisted radical prostatectomy.
Sadahira T; Mitsui Y; Araki M; Maruyama Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Low Urin Tract Symptoms; 2019 May; 11(3):122-126. PubMed ID: 30548814
[TBL] [Abstract] [Full Text] [Related]
11. Health-Related Quality of Life in 536 Long-Term prostate cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis.
Hammerer PG; Wirth MP;
Urol Int; 2018; 100(1):72-78. PubMed ID: 29183006
[TBL] [Abstract] [Full Text] [Related]
12. Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.
Wang BD; Ceniccola K; Hwang S; Andrawis R; Horvath A; Freedman JA; Olender J; Knapp S; Ching T; Garmire L; Patel V; Garcia-Blanco MA; Patierno SR; Lee NH
Nat Commun; 2017 Jun; 8():15921. PubMed ID: 28665395
[TBL] [Abstract] [Full Text] [Related]
13. RNA splicing and splicing regulator changes in prostate cancer pathology.
Munkley J; Livermore K; Rajan P; Elliott DJ
Hum Genet; 2017 Sep; 136(9):1143-1154. PubMed ID: 28382513
[TBL] [Abstract] [Full Text] [Related]
14. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract] [Full Text] [Related]
15. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.
Tsai LC; Hsieh HY; Lu KY; Wang SY; Mi FL
Nanomedicine (Lond); 2016 Jan; 11(1):9-30. PubMed ID: 26654241
[TBL] [Abstract] [Full Text] [Related]
16. Differential IKK/NF-κB Activity Is Mediated by tsc2 through mTORC1 in PTEN-Null prostate cancer and Tuberous Sclerosis Complex Tumor Cells.
Gao Y; Gartenhaus RB; Lapidus RG; Hussain A; Zhang Y; Wang X; Dan HC
Mol Cancer Res; 2015 Dec; 13(12):1602-14. PubMed ID: 26374334
[TBL] [Abstract] [Full Text] [Related]
17. AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/tsc2.
Lin HP; Lin CY; Huo C; Jan YJ; Tseng JC; Jiang SS; Kuo YY; Chen SC; Wang CT; Chan TM; Liou JY; Wang J; Chang WS; Chang CH; Kung HJ; Chuu CP
Oncotarget; 2015 Sep; 6(29):27097-112. PubMed ID: 26318033
[TBL] [Abstract] [Full Text] [Related]
18. MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy.
Tienza A; Hevia M; Benito A; Pascual JI; Zudaire JJ; Robles JE
Int Urol Nephrol; 2015 Aug; 47(8):1343-9. PubMed ID: 26049974
[TBL] [Abstract] [Full Text] [Related]
19. Adiponectin inhibits VEGF-A in prostate cancer cells.
Gao Q; Zheng J; Yao X; Peng B
Tumour Biol; 2015 Jun; 36(6):4287-92. PubMed ID: 25586350
[TBL] [Abstract] [Full Text] [Related]
20. Multivariate analysis of factors predicting prostate dose in intensity-modulated radiotherapy.
Tomita T; Nakamura M; Hirose Y; Kitsuda K; Notogawa T; Miki K; Nakamura K; Ishigaki T
Med Dosim; 2014; 39(4):360-5. PubMed ID: 25155214
[TBL] [Abstract] [Full Text] [Related]
[Next]
